Author

Francesco Graziano

A Propensity Score-Weighted Comparison of Vedolizumab, Adalimumab, and Golimumab in Patients with Ulcerative Colitis: Real-Life Data from the Sicilian Network for Inflammatory Bowel Disease (SN-IBD)

Fabio Salvatore Macaluso, Marco Ventimiglia, Walter Fries, Maria Cappello, Barbara Scrivo, Antonio Magnano, Dario Pluchino, Salvatore Camilleri, Serena Garufi, Roberto Di Mitri, Filippo Mocciaro, Giovanni Magri, Concetta Ferracane, Michele Citrano, Francesco Graziano, Carmelo Bertolami, Sara Renna, Rosalba Orlando, Giulia

SEVERE ACTIVITY OF INFLAMMATORY BOWEL DISEASE IS A RISK FACTOR FOR SEVERE COVID-19: DATA FROM THE SICILIAN NETWORK FOR INFLAMMATORY BOWEL DISEASE (SN-IBD)

Anna Viola, Alessandra Giuliano, Walter Fries, Alfredo Abbruzzese, ANTONINO CARLO Privitera, maria giovanna minissale, Lucio Carrozza, Concetta Ferracane, Fabio Salvatore Macaluso, Francesco Graziano, Carmelo Bertolami, Serena Garufi, Ugo Cucinotta, Emiliano Giangreco, Giuseppe Scalisi, Antonio Giovanni Magnano, Enrica Giuf

SPOSAB ABP 501 - A SICILIAN PROSPECTIVE OBSERVATIONAL STUDY OF PATIENTS WITH INFLAMMATORY BOWEL DISEASE TREATED WITH ADALIMUMAB BIOSIMILAR ABP 501

Fabio Salvatore Macaluso, Maria Cappello, Anita Busacca, Walter Fries, Anna Viola, Giuseppe Costantino, Antonio Magnano, Elisa Vinci, Concetta Ferracane, ANTONINO CARLO Privitera, Giovita Piccillo, Nunzio Belluardo, Emiliano Giangreco, Claudio Romano, Michele Citrano, Francesco Graziano, Serena Garufi, Carmelo Bertolami,

Item 1 - 3 / 3
1